Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007

2007 07 17 15 08 50 706

2007 07 17 15 08 50 706

Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

Telix inks deal to acquire ITM for $1.65B

September 21, 2026

Explore Innovations at EANM 2026

Explore Innovations at EANM 2026

September 16, 2026

MICSI secures FDA clearance for MR-guided PET platform

September 16, 2026

Approved Stamp 400

Curium gets FDA approval for Lu-177 injection for GEP-NETs

September 15, 2026

Telix inks deal to acquire ITM for $1.65B

By Erik L. Ridley

The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.

September 21, 2026

FES-PET guides second-line therapy decisions in breast cancer

FES-PET/CT results led to therapeutic management changes in 37.8% of patients.

September 18, 2026

MICSI secures FDA clearance for MR-guided PET platform

By AuntMinnie.com staff writers

The platform is cleared across F-18 FDG, amyloid (florbetapir, florbetaben, flutemetamol), and tau (flortaucipir) radiotracers.

September 16, 2026

Curium gets FDA approval for Lu-177 injection for GEP-NETs

By AuntMinnie.com staff writers

The radioligand therapy delivers targeted radiation to GEP-NETs by binding to somatostatin receptors expressed on these tumors.

September 15, 2026

Approved Stamp 400

CAIX-targeted PET tracer shows promise in patients with ccRCC

Ga-68 DPI-4452 PET/CT correctly identified all 23 primary clear cell renal cell carcinoma tumors, achieving 100% sensitivity.

September 14, 2026

Representative Ga-68 DPI-4452 PET/CT images of regional and distant metastases in ccRCC from multiple patients, including regional lymph node (A), bilateral adrenal glands (B), lung (C), and bone (D). For each panel, top row shows fused PET/CT images, middle row shows PET-only images, and bottom row shows unenhanced CT images. Target lesions are highlighted by white arrows on fused/CT images and black arrows on PET images.

FDA clears new PET agent for brain cancer imaging

By AuntMinnie.com staff writers

Gliomas account for approximately 30% of all brain and central nervous system tumors.

September 14, 2026

Ratio Therapeutics, RayzeBio join forces

By AuntMinnie.com staff writers

The firms will collaborate on a radiopharmaceutical program focused on two cancer targets.

September 9, 2026

Hands Shaking Deal

Coalition launches Cardiac PET Alliance

By AuntMinnie.com staff writers

The coalition represents more than 1,200 cardiologists across 101 cardiovascular group practices in 24 states.

September 9, 2026

Heart Valves Artx Premium

Siemens expands PET detector manufacturing site

By AuntMinnie.com staff writers

The project significantly increases production capacity at its East Tennessee Molecular Imaging Complex.

September 9, 2026

Siemens Pet Manufacturing Center

GEHC submits StarGuide GX digital SPECT/CT for FDA clearance

By AuntMinnie.com staff writers

The system uses dual-sided cadmium zinc telluride (CZT) detector technology for higher volume sensitivity and high-res imaging.

September 8, 2026

AtomVie opens new radiopharmaceutical manufacturing facility

By AuntMinnie.com staff writers

The new site increases the firm's manufacturing capacity by more than tenfold.

September 4, 2026

Juniper secures FDA 'breakthrough' nod for hypoxia PET tracer

By AuntMinnie.com staff writers

JBS-003, licensed from Memorial Sloan Kettering Cancer Center, identifies tumor hypoxia, a marker of radioresistance.

September 3, 2026

Page 1 of 635